Interaction of glioma-associated microglia/macrophages and anti-PD1 immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interaction of glioma-associated microglia/macrophages and anti-PD1 immunotherapy

Published:2023-01-09 Issue:6 Volume:72 Page:1685-1698
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Wang Chunhua,Chen Quan,Chen Meiqing,Guo Sizhen,Hou Ping,Zou Yulian,Wang Jun,He Bailin,Zhang Qiuyu,Chen Lieping,Luo Liqun^ORCID

Funder

Natural Science Foundation of Fujian Province

Joint Funds for the Innovation of Science and Technology

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s00262-022-03358-3.pdf

Reference44 articles.

1. Miller KD, Ostrom QT, Kruchko C, Patil N, Tihan T, Cioffi G, Fuchs HE, Waite KA, Jemal A, Siegel RL, Barnholtz-Sloan JS (2021) Brain and other central nervous system tumor statistics, 2021. CA Cancer J Clin 71(5):381–406. https://doi.org/10.3322/caac.21693

2. Zou W, Wolchok JD, Chen L (2016) PD-L1 (B7–H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations. Sci Transl Med 8(328):328rv324-328rv324. https://doi.org/10.1126/scitranslmed.aad7118

3. Ribas A, Wolchok JD (2018) Cancer immunotherapy using checkpoint blockade. Science (New York, N.Y.) 359(6382):1350–1355. https://doi.org/10.1126/science.aar4060

4. Reardon DA, Brandes AA, Omuro A, Mulholland P, Lim M, Wick A, Baehring J, Ahluwalia MS, Roth P, Bahr O, Phuphanich S, Sepulveda JM, De Souza P, Sahebjam S, Carleton M, Tatsuoka K, Taitt C, Zwirtes R, Sampson J, Weller M (2020) Effect of Nivolumab versus Bevacizumab in patients with recurrent glioblastoma: the checkmate 143 phase 3 randomized clinical trial. JAMA Oncol 6(7):1003–1010. https://doi.org/10.1001/jamaoncol.2020.1024

5. Wang X, Guo G, Guan H, Yu Y, Lu J, Yu J (2019) Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma. J Exp Clin Cancer Res CR 38(1):87. https://doi.org/10.1186/s13046-019-1085-3

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of the TCF12/VSIG4 axis by palbociclib diminishes the proliferation and migration of glioma cells and decreases the M2 polarization of glioma‐associated microglia;Drug Development Research;2024-07-05

2. Exploring the impact of ITGB2 on glioma progression and treatment: Insights from non‐apoptotic cell death and immunotherapy;Environmental Toxicology;2024-03-15

3. From glioma gloom to immune bloom: unveiling novel immunotherapeutic paradigms-a review;Journal of Experimental & Clinical Cancer Research;2024-02-12

4. Interactions between microglia and glioma in tumor microenvironment;Frontiers in Oncology;2023-08-28

5. Dynamic change in Siglec-15 expression in peritumoral macrophages confers an immunosuppressive microenvironment and poor outcome in glioma;Frontiers in Immunology;2023-05-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3